Home
Clinical Trials
A Prospective Registry For Pa...

A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.

Last Updated: 2019-05-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-30

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The incidence and prevalence of pulmonary disease due to Non-tuberculous mycobacteria (NTM) is increasing worldwide, and this trend has been confirmed in Korea. Treatment of NTM pulmonary disease is difficult and usually requires more than two years of long-term treatment, and the antibiotic regimens used in treatment vary. Therefore, it is difficult to track the natural history of patients with NTM pulmonary disease, to evaluate the treatment outcome, and to understand the effect of specific medicines on the outcome. Establishing a prospective registry of patients with NTM pulmonary disease is expected to accurately evaluate the progress, treatment modality, and treatment outcome of NTM pulmonary disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Registry for Nontuberculous Mycobacterial Pulmonary Disease

NCT04078412

Nontuberculous Mycobacterial Pulmonary Disease

ENROLLING_BY_INVITATION

Study of Nontuberculous Mycobacterial Lung Disease

NCT00970801

Nontuberculous Mycobacterial Lung Disease

RECRUITING

WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments

NCT03532438

Nontuberculous Mycobacterium Infection Whole Genome Sequencing

UNKNOWN

Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT

NCT02340897

Mycobacterium Infections, Nontuberculous

COMPLETED

Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease

NCT02832843

Mycobacterium Infections, Nontuberculous

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease Pulmonary Infection Non-Tuberculous Mycobacterial Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Clinical diagnosis of NTM pulmonary disease.
2. The causative agent of NTM pulmonary disease includes: M. avium complex, or M. abscessus subspecies abscessus, or M. abscessus subspecies massiliense, or M. kansasii.
3. Patients who starts new treatment (those who have previous history of treatment are eligible)

Exclusion Criteria

1. Patients who have been treated for more than 4 weeks.
2. The causative agent of NTM pulmonary disease is none of M. avium complex, M. abscessus subspecies abscessus, M. abscessus subspecies massiliense, or M. kansasii.

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers